Prescription drug · ANDA
Nitisinone NDC 71863-120
Nitisinone 5 mg/1 · Capsule · Oral · Eton Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71863-120-60 | 7186301206071863012060 | 1 BOTTLE in 1 CARTON (71863-120-60) / 60 CAPSULE in 1 BOTTLEMarketed from Jan 15, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Nitisinone
- Generic name (nonproprietary)
- nitisinone
- Active ingredients
- Nitisinone — 5 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Eton Pharmaceuticals, Inc.NDC labeler code 71863
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 216201
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 2C9 Inhibitors (Mechanism)Cytochrome P450 2E1 Inducers (Mechanism)Hydroxyphenylpyruvate Dioxygenase Inhibitors (Mechanism)Organic Anion Transporter 1 Inhibitors (Mechanism)Organic Anion Transporter 3 Inhibitors (Mechanism)
- Identifiers
- Product ID 71863-120_42c7c79b-1aa1-12bc-e063-6394a90a5ff8SPL ID 42c7c79b-1aa1-12bc-e063-6394a90a5ff8SPL set ID dc5e4875-fcd7-408c-88c9-4a715f4384b6RxCUI 351173, 351174, 351175, 1798999UNII K5BN214699UPC 0371863119605, 0371863120601, 0371863122605
- Pharmacologic class
- 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471863012060followed by a unit qualifier and the quantityPackage 71863-0120-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NITISINONE CAPSULES safely and effectively. See full prescribing information for NITISINONE CAPSULES. NITISINONE Capsules, for oral use Initial U.S. Approval: 2002 1. INDICATIONS AND USAGE Nitisinone Capsules is indicated for the treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine. Nitisinone is a hydroxy-phenylpyruvate dioxygenase inhibitor indicated for the treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyros…
Excerpt only. Read the full label for complete information.
About NDC 71863-120
- What is NDC 71863-120?
- 71863-120 is the product NDC for Nitisinone, Nitisinone 5 mg/1 capsule, listed with the FDA by Eton Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Nitisinone.
- What is the active ingredient?
- Nitisinone.
- Who is the labeler?
- Eton Pharmaceuticals, Inc., NDC labeler code 71863. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Nitisinone?
- 13 other product NDCs are listed under this name. See all Nitisinone NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Nitisinone products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Nitisinone | Nitisinone 2 mg/1 | CapsuleOral | Eton Pharmaceuticals, Inc. | 71863-119 | 71863-0119-60 |
| Nitisinone | Nitisinone 10 mg/1 | CapsuleOral | Eton Pharmaceuticals, Inc. | 71863-121 | 71863-0121-60 |
| Nitisinone | Nitisinone 20 mg/1 | CapsuleOral | Eton Pharmaceuticals, Inc. | 71863-122 | 71863-0122-60 |
| Nitisinone | Nitisinone 20 mg/1 | CapsuleOral | Analog Pharma | 70505-220 | 70505-0220-60 |
| Nitisinone | Nitisinone 2 mg/1 | CapsuleOral | Analog Pharma | 70505-202 | 70505-0202-60 |
| Nitisinone | Nitisinone 5 mg/1 | CapsuleOral | Analog Pharma | 70505-205 | 70505-0205-60 |
| Nitisinone | Nitisinone 10 mg/1 | CapsuleOral | Analog Pharma | 70505-210 | 70505-0210-60 |
| Nitisinone | Nitisinone 2 mg/1 | CapsuleOral | Par Health USA, LLC | 0254-3020 | 00254-3020-02 |
| Nitisinone | Nitisinone 5 mg/1 | CapsuleOral | Par Health USA, LLC | 0254-3021 | 00254-3021-02 |
| Nitisinone | Nitisinone 10 mg/1 | CapsuleOral | Par Health USA, LLC | 0254-3022 | 00254-3022-02 |
Other NDCs under ANDA 216201
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Nitisinone | Nitisinone 2 mg/1 | CapsuleOral | Eton Pharmaceuticals, Inc. | 71863-119 |
| Nitisinone | Nitisinone 10 mg/1 | CapsuleOral | Eton Pharmaceuticals, Inc. | 71863-121 |
| Nitisinone | Nitisinone 20 mg/1 | CapsuleOral | Eton Pharmaceuticals, Inc. | 71863-122 |